Abstract:Background: Pancreatic cancer has a high degree of malignancy and high mortality. Understanding its biological status can provide more therapeutic targets for the future. The present study was to investigate whether curcumin can inhibit pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α (HIF-1α)-mediated glycolytic pathway. Methods: Two pancreatic cancer cell lines, PANC-1 and SW1990, were treated with different concentrations of curcumin (0, 20, 40, and 60 µM). Cell viability was detected using the Cell Counting Kit-8 (CCK-8) assay and flow cytometry was performed to determine the apoptosis rate and cell cycle arrest of the pancreatic cancer cells. PANC-1 and SW1990 cells were treated with different concentrations of curcumin under hypoxic conditions for 48 hours to detect the relative expression of the Beclin1 protein. The co-immunoprecipitation (co-IP) method was used to determine whether curcumin could inhibit the interaction between Beclin1 and HIF-1α. Results: The proliferation inhibition rates of PANC-1 cells after exposure to 0, 20, 40, and 60 µM curcumin were 0%, 31.6%, 47.2%, and 63.9%, respectively, and that of SW1990 cells were 0%, 18.8%, 46.3%, and 63.5% respectively. Western blot analyses showed decreased expression of Beclin1 in cells treated with curcumin. The expression of Beclin1 in the nucleus and cytoplasm decreased with increasing concentrations of curcumin. Co-IP results demonstrated that curcumin inhibited the interaction between Beclin1 and HIF-1α. Treatment with the higher doses of curcumin (40 and 60 µM) significantly decreased the protein expression levels of HIF-1α. In addition, the expression levels of Kidney-Specific Cadherin (HSP70, HSP90, and von Hippel-Lindau protein (pVHL) were significantly decreased in pancreatic cancer cells while the expression of prolyl hydroxylase (PHD) and receptor of activated protein kinase C (RACK1) increased significantly. Furthermore, curcumin reduced cellular adenosine triphosphate (ATP) production in a dose-dependent manner. Compared with control pancreatic cancer cells, the expression levels of GLUT1, HK2, LDHA, and PDK1 gradually decreased with increasing curcumin concentrations. Conclusions: Curcumin can inhibit the expression of Beclin1 and HIF-1α in pancreatic cancer cells under anoxic conditions, thereby affecting the glycolysis pathway and inhibiting cell proliferation.

Curcumin-loaded emulsome nanoparticles induces apoptosis through p53 signaling pathway in pancreatic cancer cell line PANC-1

Anti-tumor Activity of Emodin on Human Pancreatic Cancer Cell Line BXPC-3 in Vivo

Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer

Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells Through Modulation of Mir-200 and Mir-21 Expression by Curcumin or Its Analogue CDF.

Combined Effects of Curcumin and γray Irradiation on PANC-1 cells in vitro

Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function

Topically Applicated Curcumin/gelatin-Blended Nanofibrous Mat Inhibits Pancreatic Adenocarcinoma by Increasing ROS Production and Endoplasmic Reticulum Stress Mediated Apoptosis

Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway

Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines

Curcumin Nicotinate Selectively Induces Cancer Cell Apoptosis and Cycle Arrest through a P53-Mediated Mechanism

Gemcitabine-loaded chitosan nanoparticles enhanced apoptotic and ferroptotic response of gemcitabine treatment alone in the pancreatic cancer cells in vitro

Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells

CP41, a Novel Curcumin Analogue, Induces Apoptosis in Endometrial Cancer Cells by Activating the H3F3A/ Proteasome-Mapk Signaling Pathway and Enhancing Oxidative Stress

Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives

Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression

Curcumin Inhibits Protein Phosphatases 2A and 5, Leading to Activation of Mitogen-Activated Protein Kinases and Death in Tumor Cells.

Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy

Molecular Mechanism of Curcumin and Its Analogs as Multifunctional Compounds against Pancreatic Cancer

Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells

Curcumin-loaded Zein/pectin Nanoparticles: Caco-2 Cellular Uptake and the Effects on Cell Cycle Arrest and Apoptosis of Human Hepatoma Cells (Hepg2)

Synergistic effect of the anti-PD-1 antibody with blood stable and reduction sensitive curcumin micelles on colon cancer